Cargando…

Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach

BACKGROUND: Antibodies (Ab) play a significant role in immunity to Plasmodium falciparum malaria. Usually, following repeated exposure to pathogens, affinity maturation and clonal selection take place, resulting in increased antibody avidity. However, some studies suggest affinity maturation may not...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Diane Wallace, Bobbili, Naveen, Kayatani, Alex, Tassi Yunga, Samuel, Kidima, Winifrida, Leke, Rose F. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195780/
https://www.ncbi.nlm.nih.gov/pubmed/32357882
http://dx.doi.org/10.1186/s12936-020-03243-3
_version_ 1783528608303677440
author Taylor, Diane Wallace
Bobbili, Naveen
Kayatani, Alex
Tassi Yunga, Samuel
Kidima, Winifrida
Leke, Rose F. G.
author_facet Taylor, Diane Wallace
Bobbili, Naveen
Kayatani, Alex
Tassi Yunga, Samuel
Kidima, Winifrida
Leke, Rose F. G.
author_sort Taylor, Diane Wallace
collection PubMed
description BACKGROUND: Antibodies (Ab) play a significant role in immunity to Plasmodium falciparum malaria. Usually, following repeated exposure to pathogens, affinity maturation and clonal selection take place, resulting in increased antibody avidity. However, some studies suggest affinity maturation may not occur to malaria antigens in endemic areas. Information on development of antibody avidity is confusing and conflicting, in part, because different techniques have been used to measure avidity. Today, bead-based multiplex immunoassays (MIA) are routinely used to simultaneously quantitate antibody levels to multiple antigens. This study evaluated the feasibility of developing an avidity MIA with 5 merozoite antigens (AMA1, EBA-175, MSP1-42, MSP2, MSP3) that uses a single chaotropic concentration. METHODS: The most common ELISA protocols that used the chaotropic reagents guanidine HCl (GdHCl), urea, and ammonium thiocyanate (NH(4)SCN) were adapted to a multiplex MIA format. Then, different concentrations of chaotropes and incubation times were compared and results were expressed as an Avidity Index (AI), i.e., percentage of antibody remaining bound in the presence of chaotrope. Experiments were conducted to (i) identify the assay with the widest range of AI (discriminatory power), (ii) determine the amount of chaotrope needed to release 50% of bound Ab using plasma from adults and infants, and (iii) evaluate assay repeatability. RESULTS: Overall, 4 M GdHCl and 8 M urea were weaker chaotropes than 3 M NH(4)SCN. For example, they failed to release significant amounts of Ab bound to MSP1-42 in adult plasma samples; whereas, a range of AI values was obtained with NH(4)SCN. Titration of NH(4)SCN revealed that 2 M NH(4)SCN gave the widest range of AI for the 5 antigens. Binding studies using plasma from 40 adults and 57 1-year old infants in Cameroon showed that 2.1 M ± 0.32 (mean ± SD) NH(4)SCN (adults) and 1.8 M ± 0.23 M (infants) released 50% of bound Ab from the merozoite antigens. CONCLUSIONS: An avidity MIA is feasible for the 5 merozoite antigens that uses a single concentration (2 M) of NH(4)SCN. The assay provides a simple method to quickly obtain information about Ab quantity and quality in the acquisition of immunity to malaria in endemic populations.
format Online
Article
Text
id pubmed-7195780
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71957802020-05-06 Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach Taylor, Diane Wallace Bobbili, Naveen Kayatani, Alex Tassi Yunga, Samuel Kidima, Winifrida Leke, Rose F. G. Malar J Research BACKGROUND: Antibodies (Ab) play a significant role in immunity to Plasmodium falciparum malaria. Usually, following repeated exposure to pathogens, affinity maturation and clonal selection take place, resulting in increased antibody avidity. However, some studies suggest affinity maturation may not occur to malaria antigens in endemic areas. Information on development of antibody avidity is confusing and conflicting, in part, because different techniques have been used to measure avidity. Today, bead-based multiplex immunoassays (MIA) are routinely used to simultaneously quantitate antibody levels to multiple antigens. This study evaluated the feasibility of developing an avidity MIA with 5 merozoite antigens (AMA1, EBA-175, MSP1-42, MSP2, MSP3) that uses a single chaotropic concentration. METHODS: The most common ELISA protocols that used the chaotropic reagents guanidine HCl (GdHCl), urea, and ammonium thiocyanate (NH(4)SCN) were adapted to a multiplex MIA format. Then, different concentrations of chaotropes and incubation times were compared and results were expressed as an Avidity Index (AI), i.e., percentage of antibody remaining bound in the presence of chaotrope. Experiments were conducted to (i) identify the assay with the widest range of AI (discriminatory power), (ii) determine the amount of chaotrope needed to release 50% of bound Ab using plasma from adults and infants, and (iii) evaluate assay repeatability. RESULTS: Overall, 4 M GdHCl and 8 M urea were weaker chaotropes than 3 M NH(4)SCN. For example, they failed to release significant amounts of Ab bound to MSP1-42 in adult plasma samples; whereas, a range of AI values was obtained with NH(4)SCN. Titration of NH(4)SCN revealed that 2 M NH(4)SCN gave the widest range of AI for the 5 antigens. Binding studies using plasma from 40 adults and 57 1-year old infants in Cameroon showed that 2.1 M ± 0.32 (mean ± SD) NH(4)SCN (adults) and 1.8 M ± 0.23 M (infants) released 50% of bound Ab from the merozoite antigens. CONCLUSIONS: An avidity MIA is feasible for the 5 merozoite antigens that uses a single concentration (2 M) of NH(4)SCN. The assay provides a simple method to quickly obtain information about Ab quantity and quality in the acquisition of immunity to malaria in endemic populations. BioMed Central 2020-05-01 /pmc/articles/PMC7195780/ /pubmed/32357882 http://dx.doi.org/10.1186/s12936-020-03243-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Taylor, Diane Wallace
Bobbili, Naveen
Kayatani, Alex
Tassi Yunga, Samuel
Kidima, Winifrida
Leke, Rose F. G.
Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_full Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_fullStr Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_full_unstemmed Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_short Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
title_sort measuring antibody avidity to plasmodium falciparum merozoite antigens using a multiplex immunoassay approach
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195780/
https://www.ncbi.nlm.nih.gov/pubmed/32357882
http://dx.doi.org/10.1186/s12936-020-03243-3
work_keys_str_mv AT taylordianewallace measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT bobbilinaveen measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT kayatanialex measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT tassiyungasamuel measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT kidimawinifrida measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach
AT lekerosefg measuringantibodyaviditytoplasmodiumfalciparummerozoiteantigensusingamultipleximmunoassayapproach